{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:55:44Z","timestamp":1776801344957,"version":"3.51.2"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Dyspnea and exercise intolerance are usually attributed to pulmonary disease in sarcoidosis patients. However, cardiac involvement may also be responsible for these symptoms. Data regarding the impact of heart involvement on lung function in cardiac sarcoidosis (CS) is limited.<\/jats:p>\n            <jats:p>The aim of study was to compare the results of pulmonary function tests (PFTs) in patients with and without heart involvement. We performed a retrospective analysis of PFTs in a group of sarcoidosis patients both with and without heart involvement evaluated by cardiovascular magnetic resonance (CMR) study. The study was performed in the period between May 2008 and April 2016.<\/jats:p>\n            <jats:p>We included data of sarcoidosis patients who underwent testing for possible CS (including CMR study) at a national tertiary referral center for patients with interstitial lung diseases. All patients had histopathologicaly confirmed sarcoidosis and underwent standard evaluation with PFTs measurements including spirometry, plethysmography, lung transfer factor (<jats:italic toggle=\"yes\">T<\/jats:italic>\n                                 <jats:sub>L,CO<\/jats:sub>), and 6-minute walking test (6MWT) assessed using the most recent predicted values.<\/jats:p>\n            <jats:p>We identified 255 sarcoidosis patients (93 women, age 42\u200a\u00b1\u200a10.7 y): 103 with CS and 152 without CS (controls). CS patients had significantly lower left ventricular ejection fraction (LVEF; 56.9\u200a\u00b1\u200a7.0 vs 60.4\u200a\u00b1\u200a5.4, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Any type of lung dysfunction was seen in 63% of CS patients compared with 31% in the controls (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.005). Ventilatory disturbances (obstructive or restrictive pattern) and low <jats:italic toggle=\"yes\">T<\/jats:italic>\n                                 <jats:sub>L,CO<\/jats:sub> were more frequent in CS group (52% vs 23%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001 and 38% vs 18% <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01 respectively). CS (OR\u200a=\u200a2.13, 95% CI: 1.11\u20134.07, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.02), stage of the disease (OR\u200a=\u200a3.13, 95% CI: 1.4\u20137.0, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.006) and LVEF (coefficient\u200a=\u200a\u20130.068\u200a\u00b1\u200a0.027, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.011) were independent factors associated with low FEV<jats:sub>1<\/jats:sub> but not low <jats:italic toggle=\"yes\">T<\/jats:italic>\n                                 <jats:sub>L,CO<\/jats:sub>. There was a significant correlation between LVEF and FEV<jats:sub>1<\/jats:sub> in CS group (<jats:italic toggle=\"yes\">r<\/jats:italic>\u200a=\u200a0.31, <jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a89, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003). No significant difference in 6MWD between CS patients and controls was observed.<\/jats:p>\n            <jats:p>Lung function impairment was more frequent in CS. Lower LVEF was associated with decreased values of FEV<jats:sub>1<\/jats:sub>. Relatively poor lung function may be an indication of cardiac sarcoidosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018037","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:58:05Z","timestamp":1574665085000},"page":"e18037","source":"Crossref","is-referenced-by-count":4,"title":["Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?"],"prefix":"10.1097","volume":"98","author":[{"given":"Magdalena M.","family":"Martusewicz-Boros","sequence":"first","affiliation":[{"name":"3Lung Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr W.","family":"Boros","sequence":"additional","affiliation":[{"name":"Lung Pathophysiology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wiatr","sequence":"additional","affiliation":[{"name":"3Lung Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Zych","sequence":"additional","affiliation":[{"name":"3Lung Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kempisty","sequence":"additional","affiliation":[{"name":"1Lung Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kram","sequence":"additional","affiliation":[{"name":"Rehabilitation Department, National TB & Lung Diseases Research Institute, Warsaw"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Piotrowska-Kownacka","sequence":"additional","affiliation":[{"name":"1Department of Clinical Radiology, Medical University of Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Weso\u0142owski","sequence":"additional","affiliation":[{"name":"Lung Pathophysiology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazimierz","family":"Roszkowski-Sli\u017c","sequence":"additional","affiliation":[{"name":"3Lung Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230915","first-page":"736","article-title":"Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","author":"Statement on sarcoidosis","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1183\/09031936.00166809","article-title":"Impaired lung compliance and DL, CO but no restrictive ventilatory defect in sarcoidosis","volume":"36","author":"Boros","year":"2010","journal-title":"Eur Respir J"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1378\/chest.78.4.640","article-title":"Use of pulmonary-function tests in the management of sarcoidosis","volume":"78","author":"Winterbauer","year":"1980","journal-title":"Chest"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.93.06030349","article-title":"Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage","volume":"6","author":"Viskum","year":"1993","journal-title":"Eur Respir J"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20230915","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"R9-20230915","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"e4518","DOI":"10.1097\/MD.0000000000004518","article-title":"Prevalence of cardiac sarcoidosis in white population: a case-control study: proposal for a novel risk index based on commonly available tests","volume":"95","author":"Martusewicz-Boros","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00408-015-9805-8","article-title":"Cardiac sarcoidosis: is it more common in men?","volume":"194","author":"Martusewicz-Boros","year":"2016","journal-title":"Lung"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: a JACC White Paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R14-20230915","first-page":"19","article-title":"The WASOG Sarcoidosis Organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","article-title":"Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing","volume":"15","author":"Schulz-Menger","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur Respir J"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"Macintyre","year":"2005","journal-title":"Eur Respir J"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"R21-20230915","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00010-2017","article-title":"Official ERS technical standards: global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians","volume":"50","author":"Stanojevic","year":"2017","journal-title":"Eur Respir J"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"Laboratories ATSCoPSfCPF","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.rmed.2006.02.004","article-title":"The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis","volume":"100","author":"Lettieri","year":"2006","journal-title":"Respir Med"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1465-9921-15-15","article-title":"Cardiac involvement in Caucasian patients with pulmonary sarcoidosis","volume":"15","author":"Darlington","year":"2014","journal-title":"Respir Res"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","article-title":"Cardiac sarcoidosis: a retrospective study of 41 cases","volume":"83","author":"Chapelon-Abric","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.14-0139","article-title":"Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation","volume":"146","author":"Nagai","year":"2014","journal-title":"Chest"},{"key":"R30-20230915","first-page":"27","article-title":"Significance of plasma Nt-Probnp levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis","volume":"27","author":"Handa","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00408-012-9406-8","article-title":"Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis","volume":"190","author":"Krell","year":"2012","journal-title":"Lung"},{"key":"R32-20230915","first-page":"99","article-title":"Bronchial hyperreactivity in sarcoidosis patients: correlation with airflow limitation indices","volume":"29","author":"Martusewicz-Boros","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1378\/chest.103.5.1477","article-title":"Bronchial hyperreactivity in patients with moderate pulmonary circulation overload","volume":"103","author":"Brunnee","year":"1993","journal-title":"Chest"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.hlc.2013.08.003","article-title":"Lung function abnormalities are highly frequent in patients with heart failure and preserved ejection fraction","volume":"23","author":"Andrea","year":"2014","journal-title":"Heart Lung Circ"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijcard.2016.05.034","article-title":"Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population","volume":"218","author":"Baum","year":"2016","journal-title":"Int J Cardiol"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1183\/09031936.00117710","article-title":"Exercise capacity, muscle strength and fatigue in sarcoidosis","volume":"38","author":"Marcellis","year":"2011","journal-title":"Eur Respir J"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2466-10-42","article-title":"Outcome measures of the 6\u200aminute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis","volume":"10","author":"Alhamad","year":"2010","journal-title":"BMC Pulm Med"},{"key":"R38-20230915","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7525-10-67","article-title":"Distance saturation product predicts health-related quality of life among sarcoidosis patients","volume":"10","author":"Bourbonnais","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/clc.21982","article-title":"Cardiac sarcoid: a Clinician's review on how to approach the patient with cardiac sarcoid","volume":"35","author":"Mantini","year":"2012","journal-title":"Clin Cardiol"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:06:56Z","timestamp":1694815616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018037"}},"subtitle":["A case-control study"],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"47","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018037","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}